SRTS Q3'26 Earnings: revenue estimate is 6.61M USD
Sensus Healthcare (SRTS) will report Q3'26 earnings on October 29. Analysts expect revenue of $6.61M and EPS of -$0.06. The announcement is scheduled for 8:00 AM ET.
How this was made

The 30-second read
Why it matters
The preview sets expectations but does not provide new material information.
Market read
Earnings preview of a small‑cap biotech; limited trading relevance until actual results.
What to watch
Potential hidden catalysts such as new product launches or regulatory updates not mentioned.
Background
Sensus Healthcare is a micro‑cap biotech listed on NASDAQ under SRTS.
Ticker impact
Article previews Sensus Healthcare's Q3'26 earnings with revenue estimate of $6.61M and EPS of -$0.06, scheduled for release Oct 29.
likely modest pressure as investors await actual results
No new earnings data, only estimates; traders may hold positions until the actual release.
Market effects
Limited impact on healthcare sector; small‑cap earnings preview.
US market focus due to NASDAQ listing.
Low
Counterpoint
If the company beats the modest estimate, the stock could rally sharply.
Key entities
- companySensus Healthcare, Inc.
US‑listed biotech company reporting Q3'26 earnings.
